These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35305724)

  • 21. Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims.
    Kini RM; Sidhu SS; Laustsen AH
    Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30551565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring the Utility of ssDNA Aptamers Directed against Snake Venom Toxins as New Therapeutics for Snakebite Envenoming.
    Alomran N; Chinnappan R; Alsolaiss J; Casewell NR; Zourob M
    Toxins (Basel); 2022 Jul; 14(7):. PubMed ID: 35878207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the pathogenic threat of envenoming by South African shield-nosed and coral snakes (genus Aspidelaps), and revealing the likely efficacy of available antivenom.
    Whiteley G; Casewell NR; Pla D; Quesada-Bernat S; Logan RAE; Bolton FMS; Wagstaff SC; Gutiérrez JM; Calvete JJ; Harrison RA
    J Proteomics; 2019 Apr; 198():186-198. PubMed ID: 30290233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antivenoms for snakebite envenomings.
    Gutiérrez JM; León G; Lomonte B; Angulo Y
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):369-80. PubMed ID: 21745181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment outcomes among snakebite patients in north-west Ethiopia-A retrospective analysis.
    Steegemans I; Sisay K; Nshimiyimana E; Gebrewold G; Piening T; Menberu Tessema E; Sahelie B; Alcoba G; Gebretsadik FS; Essink D; Collin S; Lucero E; Ritmeijer K
    PLoS Negl Trop Dis; 2022 Feb; 16(2):e0010148. PubMed ID: 35139079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and Characterization of Anti-
    Manson EZ; Kyama MC; Kimani J; Bocian A; Hus KK; Petrilla V; Legáth J; Kimotho JH
    Toxins (Basel); 2022 Apr; 14(4):. PubMed ID: 35448894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two snakebite antivenoms have potential to reduce Eswatini's dependency upon a single, increasingly unavailable product: Results of preclinical efficacy testing.
    Menzies SK; Litschka-Koen T; Edge RJ; Alsolaiss J; Crittenden E; Hall SR; Westhorpe A; Thomas B; Murray J; Shongwe N; Padidar S; Lalloo DG; Casewell NR; Pons J; Harrison RA
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010496. PubMed ID: 36108067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of camelid IgG for antivenom development: Serological responses of venom-immunised camels to prepare either monospecific or polyspecific antivenoms for West Africa.
    Cook DA; Owen T; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(3):363-72. PubMed ID: 20362604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial.
    Potet J; Smith J; McIver L
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007551. PubMed ID: 31233536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful Management of Two Patients with Intracranial Hemorrhage due to Carpet Viper (Echis ocellatus) Envenomation in a Limited-Resource Environment.
    Benjamin JM; Chippaux JP; Tamou-Sambo B; Akpakpa OC; Massougbodji A
    Wilderness Environ Med; 2019 Sep; 30(3):295-301. PubMed ID: 31229367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa.
    Hamza M; Idris MA; Maiyaki MB; Lamorde M; Chippaux JP; Warrell DA; Kuznik A; Habib AG
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004568. PubMed ID: 27027633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo neutralization of dendrotoxin-mediated neurotoxicity of black mamba venom by oligoclonal human IgG antibodies.
    Laustsen AH; Karatt-Vellatt A; Masters EW; Arias AS; Pus U; Knudsen C; Oscoz S; Slavny P; Griffiths DT; Luther AM; Leah RA; Lindholm M; Lomonte B; Gutiérrez JM; McCafferty J
    Nat Commun; 2018 Oct; 9(1):3928. PubMed ID: 30279409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
    Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antivenom for European Vipera species envenoming.
    Lamb T; de Haro L; Lonati D; Brvar M; Eddleston M
    Clin Toxicol (Phila); 2017 Jul; 55(6):557-568. PubMed ID: 28349771
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of
    Kurtović T; Lang Balija M; Brvar M; Dobaja Borak M; Mateljak Lukačević S; Halassy B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33805701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First clinical experiences with specific sheep Fab fragments in snake bite. Report of a multicentre study of Vipera berus envenoming.
    Karlson-Stiber C; Persson H; Heath A; Smith D; al-Abdulla IH; Sjöström L
    J Intern Med; 1997 Jan; 241(1):53-8. PubMed ID: 9042094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vulnerability to snakebite envenoming: a global mapping of hotspots.
    Longbottom J; Shearer FM; Devine M; Alcoba G; Chappuis F; Weiss DJ; Ray SE; Ray N; Warrell DA; Ruiz de Castañeda R; Williams DJ; Hay SI; Pigott DM
    Lancet; 2018 Aug; 392(10148):673-684. PubMed ID: 30017551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatment for venom-induced consumption coagulopathy resulting from snakebite.
    Maduwage K; Isbister GK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential procoagulant effects of saw-scaled viper (Serpentes: Viperidae: Echis) snake venoms on human plasma and the narrow taxonomic ranges of antivenom efficacies.
    Rogalski A; Soerensen C; Op den Brouw B; Lister C; Dashevsky D; Arbuckle K; Gloria A; Zdenek CN; Casewell NR; Gutiérrez JM; Wüster W; Ali SA; Masci P; Rowley P; Frank N; Fry BG
    Toxicol Lett; 2017 Oct; 280():159-170. PubMed ID: 28847519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.